Novel Biomarkers for Prediction of Response to Preoperative Systemic Therapies in Gastric Cancer
Authors:
- Alessandro CavaliereACAlessandro Cavaliere
- Valeria MerzValeria Merz
- Simona CasalinoSCSimona Casalino
- Camilla ZecchettoCZCamilla Zecchetto
- Francesca SimionatoFSFrancesca Simionato
- Hayley Louise SaltHSHayley Louise Salt
- Serena ContarelliSCSerena Contarelli
- Raffaela SantoroRSRaffaela Santoro
- Davide MelisiDMDavide Melisi
Open Access
- 1 January 2019
- journal article
- review article
- Published by XMLink in Journal of Gastric Cancer
- Vol. 19 (4) , 375-392
Abstract
Cavaliere A, et al. J Gastric Cancer. 2019 Apr;19:e39. https://doi.org/10.5230/jgc.2019.19.e39Keywords
Funding Information
- Associazione Italiana per la Ricerca sul Cancro Investigator (19111, 12182)
- Università degli Studi di Verona
- Nastro Viola
- Voglio il Massimo
This publication has 99 references indexed in Scilit:
- Anti-VEGF Treatment–Resistant Pancreatic Cancers Secrete Proinflammatory Factors That Contribute to Malignant Progression by Inducing an EMT Cell PhenotypeClinical Cancer Research, 2011
- Modulation of Pancreatic Cancer Chemoresistance by Inhibition of TAK1JNCI: Journal of the National Cancer Institute, 2011
- Clinicopathological significance of platelet-derived growth factor (PDGF)-B and vascular endothelial growth factor-A expression, PDGF receptor-β phosphorylation, and microvessel density in gastric cancerBMC Cancer, 2010
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trialThe Lancet, 2010
- Phase I Pharmacologic and Biologic Study of Ramucirumab (IMC-1121B), a Fully Human Immunoglobulin G1 Monoclonal Antibody Targeting the Vascular Endothelial Growth Factor Receptor-2Journal of Clinical Oncology, 2010
- IAPs: What's in a Name?Molecular Cell, 2008
- Molecular basis of gastric cancer development and progressionGastric Cancer, 2004
- Receptor interacting protein is ubiquitinated by cellular inhibitor of apoptosis proteins (c‐IAP1 and c‐IAP2) in vitroFEBS Letters, 2004
- The tumour-suppressor function of PTEN requires an N-terminal lipid-binding motifBiochemical Journal, 2004
- Identification of Fibroblast Growth Factor 9 (FGF9) as a High Affinity, Heparin Dependent Ligand for FGF Receptors 3 and 2 but not for FGF Receptors 1 and 4Growth Factors, 1995